Sign inGet started

Kapur Anil

Insider CIK 1730703 · ATNM Chief Commercial Officer · VSTM Director · NRIX Director · GERN EVP, Corp Strategy & CCO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VSTM Verastem, Inc. A Award2026-05-212026-05-2636,000— $052,666SEC↗
NRIX Nurix Therapeutics, Inc. A Award deriv2026-05-152026-05-1531,250— $031,250SEC↗
VSTM Verastem, Inc. A Award deriv2025-05-222025-05-2712,500— $012,500SEC↗
VSTM Verastem, Inc. A Award2025-05-222025-05-278,333— $016,666SEC↗
NRIX Nurix Therapeutics, Inc. A Award deriv2025-05-192025-05-1925,000— $025,000SEC↗
NRIX Nurix Therapeutics, Inc. A Award deriv2024-10-152024-10-1650,000— $050,000SEC↗
VSTM Verastem, Inc. A Award deriv2024-06-182024-06-2012,500— $012,500SEC↗
VSTM Verastem, Inc. A Award2024-06-182024-06-208,333— $08,333SEC↗
GERN GERON CORP M Exercise deriv2024-06-102024-06-12421,875— $0328,125SEC↗
GERN GERON CORP S Sale2024-06-102024-06-12421,875$4.65 $1.96M0SEC↗
GERN GERON CORP M Exercise2024-06-102024-06-12421,875$1.06 $447.2K421,875SEC↗
GERN GERON CORP A Award deriv2024-06-062024-06-07250,000— $0250,000SEC↗
GERN GERON CORP A Award deriv2024-02-142024-02-16750,000— $0750,000SEC↗
GERN GERON CORP A Award2023-06-302023-06-307,567$2.04 $15.4K60,783SEC↗
VSTM Verastem, Inc. A Award deriv2023-05-152023-05-1662,500— $062,500SEC↗
GERN GERON CORP A Award deriv2023-02-222023-02-24625,000— $0625,000SEC↗
GERN GERON CORP A Award2022-12-302023-01-036,021$1.11 $6.7K53,216SEC↗
VSTM Verastem, Inc. A Award deriv2022-10-202022-10-24163,185— $0163,185SEC↗
GERN GERON CORP A Award2022-06-302022-07-0113,062$1.11 $14.5K47,195SEC↗
GERN GERON CORP A Award deriv2022-02-162022-02-18750,000— $0750,000SEC↗
GERN GERON CORP A Award deriv2021-02-022021-02-04300,000— $0300,000SEC↗
GERN GERON CORP A Award deriv2019-12-022019-12-04700,000— $0700,000SEC↗
ATNM Actinium Pharmaceuticals, A Award deriv2019-07-122019-07-16400,000$0.23 $92.0K400,000SEC↗